Skip to main content

Table 3 Univariate and multivariate Cox regression analysis for OMG conversion and CSR

From: Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis

  Univariate Multivariate
HR (95% CI) p value HR (95% CI) p value
Conversion
 RNS (+) 7.462 (1.651–33.718) 0.009* 6.007 (1.316–27.412) 0.021*
 Anti-AchR Ab (+) 6.428 (0.832–49.681) 0.075   
 B2/B3 thymoma versus Hyperplasia + AB/B1 thymoma 5.987 (1.325–27.044) 0.020* 4.611 (1.010–21.043) 0.048*
CSR
 Onset age > 60 versus ≤ 60 0.230 (0.052–1.011) 0.052   
 RNS (+) 0.378 (0.122–1.175) 0.093   
 Anti-AchR Ab (+) 0.396 (0.147–1.068) 0.067   
 Stage II/III thymoma versus Hyperplasia + stage I thymoma 0.300 (0.104–0.864) 0.026* 0.300 (0.104–0.864) 0.026*
  1. Values in boldface as well as * indicate statistically significant
  2. CSR complete stable remission, OMG ocular myasthenia gravis, AChR-ab anti-acetylcholine receptor antibody, RNS repetitive nerve stimulation, HR hazard ratio
  3. *Statistically significant